Q4 2022 Kane Biotech Inc Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the Kane Biotech fourth-quarter and full-year 2022 financial results and company update. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Nicole Sendey, Investor Relations. Please go ahead.
Thank you, operator. Good afternoon, and welcome everyone to Kane Biotech's quarterly earnings conference call. We're delighted to have you join us today.
This call will cover key financial and operating results for the fourth quarter and year ended December 31, 2022, along with a discussion of some of our recent highlights and goals for 2023 and beyond. Our call today will be led by Kane's Chief Executive Officer, Marc Edwards.
Before we begin our formal remarks, I would like to remind everyone that some of the statements on this conference call contain certain forward-looking information and statements within the meaning of securities law,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |